Janssen-Cilag (JNJ) Submits MA to EMA for Canagliflozin, Metformin in Type 2 Diabetes

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. SPY
4. BILL
5. WMT
6. ADI
7. ROST
8. MRK
9. MRNA
10. MRVL

Go back to Janssen-Cilag (JNJ) Submits MA to EMA for Canagliflozin, Metformin in Type 2 Diabetes
Johnson & Johnson (NYSE: JNJ) Delayed: 267.37 -6.04 (2.21%)
Previous Close $273.41    52 Week High $126.07 
Open $273.40    52 Week Low $94.28 
Day High $273.40    P/E 55.59 
Day Low $267.37    EPS $4.81 
Volume 6,451,166